Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer

Completed

Conditions studied: Lung Cancer

In brief

The purpose of this study is to study whether the presence of lung cancer in your body can be detected by testing the blood, and if the results of these blood tests change as your tumor shrinks or grows.

Key facts

Study ID

NCT00579462

Run by

Memorial Sloan Kettering Cancer Center

People needed

281

Starts

2003-01-01

Expected to finish

2010-11-01

Last updated by the study team

2010-12-01

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pathologically proven advanced (stage III-IV) lung cancer
• Measurable and/or evaluable disease
• Enrollment in an MSKCC protocol of experimental chemotherapy with radiologic response rate as an efficacy outcome variable, or prescription of standard chemotherapy in which the patient will be receiving routine radiological scans (every 4-8 weeks) as standard clinical practice.
• Signed written informed consent

You may not qualify if…

• None

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.